Last Updated: June 9, 2026

CLINICAL TRIALS PROFILE FOR KENALOG IN ORABASE


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for KENALOG IN ORABASE

Trial ID Title Status Sponsor Phase Start Date Summary
NCT02329600 ↗ Evaluation of Green Tea as Antioxidant Agent in Management of Oral Lichen Planus Completed Cairo University Phase 3 2013-06-01 The study included forty individuals divided into 3 groups. 10 control subjects, 15 oral lichen planus (OLP) patients who were treated with topical corticosteroids and 15 oral lichen planus (OLP) patients who were treated with topical corticosteroids and green tea tablets.
NCT06910579 ↗ Oxygenated Gel Therapy in the Management of Oral Aphthous Ulcers RECRUITING British University In Egypt PHASE2 2025-03-15 Interventions of both groups: Oxygenated gel Group: 15 patients who used oxygenated gel (Bluem, Wijhe, Netherlands) were trained by the co-investigator (A.H) through real demonstration for topical application of the gel on aphthous ulcers, which entails the application of 1-2 ml of oxygenated gel directly to the ulcer two times per day and this was repeated for 7 days. Triamcinolone acetonide Group: 15 patients were treated with Kenalog in orabase (Triamcinolone acetonide 0.1% oral paste 5g), four times (i.e., at 8 am, 12 noon, 4 pm, and 8 pm) a day for 7 days at intervention group. Patients in both groups were reexamined after treatment at different intervals (day 3, day 5, day 7, and day 10).
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for KENALOG IN ORABASE

Condition Name

Condition Name for KENALOG IN ORABASE
Intervention Trials
Aphthus Ulcer 1
Oral Lichen Planus 1
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for KENALOG IN ORABASE
Intervention Trials
Lichen Planus, Oral 1
Lichen Planus 1
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for KENALOG IN ORABASE

Trials by Country

Trials by Country for KENALOG IN ORABASE
Location Trials
Egypt 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for KENALOG IN ORABASE

Clinical Trial Phase

Clinical Trial Phase for KENALOG IN ORABASE
Clinical Trial Phase Trials
PHASE2 1
Phase 3 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for KENALOG IN ORABASE
Clinical Trial Phase Trials
Completed 1
RECRUITING 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for KENALOG IN ORABASE

Sponsor Name

Sponsor Name for KENALOG IN ORABASE
Sponsor Trials
Cairo University 1
British University In Egypt 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for KENALOG IN ORABASE
Sponsor Trials
Other 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.